Options
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
angiotensin
neuroprotection
Parkinson’s disease
renin
treatment
angiotensin 1 recepto...
angiotensin II
angiotensin receptor
dipeptidyl carboxypep...
dopamine
levodopa
reactive oxygen metab...
angiotensin 1 recepto...
antiparkinson agent
dipeptidyl carboxypep...
dopamine
neuroprotective agent...
reactive oxygen metab...
brain region
dopaminergic nerve ce...
drug effect
drug targeting
human
levodopa-induced dysk...
nerve degeneration
neuroprotection
nonhuman
Parkinson disease
renin angiotensin ald...
Review
animal
drug design
drug effects
metabolism
molecularly targeted ...
Parkinson disease
pathophysiology
randomized controlled...
renin angiotensin ald...
Angiotensin II Type 1...
Angiotensin-Convertin...
Animals
Antiparkinson Agents
Dopamine
Drug Design
Humans
Molecular Targeted Th...
Neuroprotective Agent...
Parkinson Disease
Randomized Controlled...
Reactive Oxygen Speci...
Renin-Angiotensin Sys...